Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 May;41(5):1422-31.
doi: 10.1016/j.ultrasmedbio.2014.12.021. Epub 2015 Feb 2.

Quantifying activation of perfluorocarbon-based phase-change contrast agents using simultaneous acoustic and optical observation

Affiliations

Quantifying activation of perfluorocarbon-based phase-change contrast agents using simultaneous acoustic and optical observation

Sinan Li et al. Ultrasound Med Biol. 2015 May.

Abstract

Phase-change contrast agents in the form of nanoscale droplets can be activated into microbubbles by ultrasound, extending the contrast beyond the vasculature. This article describes simultaneous optical and acoustical measurements for quantifying the ultrasound activation of phase-change contrast agents over a range of concentrations. In experiments, decafluorobutane-based nanodroplets of different dilutions were sonicated with a high-pressure activation pulse and two low-pressure interrogation pulses immediately before and after the activation pulse. The differences between the pre- and post-interrogation signals were calculated to quantify the acoustic power scattered by the microbubbles activated over a range of droplet concentrations. Optical observation occurred simultaneously with the acoustic measurement, and the pre- and post-microscopy images were processed to generate an independent quantitative indicator of the activated microbubble concentration. Both optical and acoustic measurements revealed linear relationships to the droplet concentration at a low concentration range <10(8)/mL when measured at body temperature. Further increases in droplet concentration resulted in saturation of the acoustic interrogation signal. Compared with body temperature, room temperature was found to produce much fewer and larger bubbles after ultrasound droplet activation.

Keywords: Acoustic droplet vaporization; Concentration; Contrast agent; Microbubble; Perfluorocarbon droplet; Phase change; Quantification; Temperature.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Microscopic images focused at the top and bottom planes of the cytometer containing microbubbles only (a, c) and droplets with few spontaneously activated bubbles (b, d). Bar = 20 μm.
Fig. 2
Fig. 2
Schematic of experimental setup.
Fig. 3
Fig. 3
Procedure for optical quantification of acoustic droplet activation (a–d). Bar = 20 μm.
Fig. 4
Fig. 4
Microscopic images (a–f) and corresponding interrogation echo signals (g–l) acquired before and after the “activation pulse” in droplets and controls. Bar = 20 μm.
Fig. 5
Fig. 5
Power spectral density (PSD) of the “difference signal” detected with droplets and control.
Fig. 6
Fig. 6
(a–d) Microscopic images of variously diluted droplet emulsions acquired after droplet vaporization. Bar = 20 μm. (e) Optical quantification as an indicator of the concentration of generated bubbles. Data at relative concentrations >0.04 (stars) were not included in the linear fitting.
Fig. 7
Fig. 7
Acoustic measurement of droplet vaporization: (a) power spectral density and (b) power of the interrogation “difference signal.” Data at relative concentrations 0–2% (diamond markers) were used in the linear fitting, as illustrated in the inset in (b).
Fig. 8
Fig. 8
Microscopic images of the acoustically vaporized droplets at different temperatures. (a) Undiluted droplets activated at 21°C. (b) Droplets diluted to 1:3 and activated at 37°C. Bar = 20 μm.
Fig. 9
Fig. 9
(a) Acoustic and (b) optical quantification of droplet activation at 21°C. Both measurements (50 repetitions) were normalized to the results measured using the droplets with a relative concentration of 0.2 (20%).

Similar articles

Cited by

References

    1. Albrecht T, Cosgrove DO, Correas JM, Rallidis L, Nihoyanopoulos P, Patel N. Renal, hepatic, and cardiac enhancement on Doppler and gray-scale sonograms obtained with EchoGen. Acad Radiol. 1996;3(Suppl 2):S198–S200. - PubMed
    1. Coli S, Magnoni M, Sangiorgi G, Marrocco-Trischitta MM, Melisurgo G, Mauriello A, Spagnoli L, Chiesa R, Cianflone D, Maseri A. Contrast-enhanced ultrasound imaging of intraplaque neovascularization in carotid arteriescorrelation with histology and plaque echogenicity. J Am Coll Cardiol. 2008;52:223–230. - PubMed
    1. Correas JM, Meuter AR, Singlas E, Kessler DR, Worah D, Quay SC. Human pharmacokinetics of a perfluorocarbon ultrasound contrast agent evaluated with gas chromatography. Ultrasound Med Biol. 2001;27:565–570. - PubMed
    1. Cosgrove D. Ultrasound contrast agents: An overview. Eur J Radiol. 2006;60:324–330. - PubMed
    1. Cosgrove DO. A revolution in liver ultrasound. Eur J Gastroenterol Hepatol. 2007;19:1–2. - PubMed

Publication types